CR2 is the primary acceptor site for C3 during alternative pathway activation of complement on human peripheral B lymphocytes.
(Q44812908)
scientific article published in July 1994
scientific article published in July 1994
Language:
Current Data About
CR2 is the primary acceptor site for C3 during alternative pathway activation of complement on human peripheral B lymphocytes.